Advanced Tumor Marker Testing
PSA, CA125 & CA19.9 | Expert Cancer Screening in Dubai
Prenez votre rendez-vous
Avis verifies des patients du centre de diagnostic DCDC a Dubai
Avis verifies et temoignages reels de patients de Dubai Healthcare City
Je suis très satisfaite de cette clinique médicale. J'ai fait mon premier dépistage de grossesse ici. C'était abordable et très professionnel. Le radiologue était accueillant, gentil et a rendu l'expérience formidable.
Aizhan Tokmanbetova
Je me suis blessée au genou vendredi soir et j'ai obtenu un rendez-vous IRM dimanche soir (réservé dimanche après-midi). J'ai attendu environ 2 minutes et c'était terminé en un peu plus de 30 minutes. L'équipe était incroyable, sympathique et efficace.
Kirsten Evans
L'équipe du Dr Osama était douce et incroyable. Après une mauvaise expérience ailleurs, mon examen pelvien ici était beaucoup plus professionnel. Excellent rapport et très précis.
Mary
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.
Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.
Dr. Hadi Komshi
Nos services Tumor Markers
Services tumor markers complets au DCDC Dubai Healthcare City.
PSA Testing
Total PSA for prostate cancer screening and monitoring in men over 40.
CA125 Testing
Ovarian cancer marker for risk assessment, diagnosis support, and treatment monitoring.
CA19.9 Testing
Pancreatic and gastrointestinal cancer marker for evaluation and follow-up.
Comprehensive Cancer Screening Panel
Combined PSA, CA125, and CA19.9 panel for thorough cancer marker evaluation.
Tous les services realises par des specialistes agrees DHA
Qui devrait beneficier de Tumor Markers ?
Tumor marker testing is recommended for individuals with risk factors for cancer, those with symptoms that may suggest malignancy, and patients undergoing cancer treatment monitoring. Your physician may order these tests based on clinical findings, family history, or screening guidelines.
Men over 50, or over 40 with family history of prostate cancer, for PSA screening
Women with pelvic masses, bloating, or family history of ovarian cancer for CA125
Patients with unexplained abdominal pain, weight loss, or jaundice for CA19.9
Individuals with a first-degree relative diagnosed with prostate, ovarian, or pancreatic cancer
Patients with known cancer undergoing treatment for response monitoring
Post-treatment cancer survivors for recurrence surveillance
Why Choose DCDC for Tumor Marker Testing?
MOHAP-licensed laboratory with advanced immunoassay technology, rapid turnaround, and integrated specialist referral pathways for comprehensive cancer screening.
MOHAP Licensed
Accredited diagnostic laboratory with certified tumor marker testing protocols and quality assurance.
Rapid Results
Most tumor marker results ready within 24-48 hours for timely clinical decision-making.
Insurance Support
Direct billing with 20+ insurers. Tumor markers typically covered with physician referral.
Convenient Location
Building 64, Block A in Dubai Healthcare City. Walk-ins welcome with appointment preferred.
Advanced Immunoassay
State-of-the-art analyzers calibrated to international reference standards for reliable results.
Specialist Integration
On-site internists, gynaecologists, and urologists for immediate follow-up of abnormal findings.
Votre visite en tout confort
Un processus d'examen Tumor simple, etape par etape, concu pour le confort, la rapidite et la precision.
Tumor Marker Testing Pricing
Les tarifs Tumor à Dubaï varient selon le type de service et la couverture d'assurance pour différents types de services.
- Les tarifs varient selon le type d'examen et la necessite de produit de contraste
- Couverture d'assurance acceptee avec ordonnance et verification
- Tarifs transparents pour paiement direct avec devis instantane sur demande
Verification d'assurance en quelques minutes - Pas de frais caches - Reponse rapide sur WhatsApp
Guide du patient
What to Expect During Tumor Marker Testing
A simple blood draw with minimal preparation and fast turnaround.
Assurance et localisation
Partenaires d'assurance
- •Plus de 20 assureurs à Dubaï dont Daman, AXA, ADNIC et d'autres
- •Assistance pré-autorisation et facturation directe (le cas échéant)
- •Vérification de la couverture avant votre rendez-vous dans notre clinique de Dubai Healthcare City
- •Tarification transparente sans frais cachés pour les services de tumor markers
Rendez-nous visite a Dubai Healthcare City
Doctors Clinic Diagnostic Center
Batiment 64, Bloc A, Al Razi Medical Complex, Dubai Healthcare City, Dubai, EAU
Pres de Oud Metha Road - Acces facile depuis Bur Dubai, Downtown Dubai, Business Bay - Parking gratuit dedie disponible
Horaires d'ouverture
Sam-Jeu : 8h - 22h | Ven : 9h - 21h
Comment fonctionne l'assurance chez DCDC
Vérifier la couverture
Vérifiez que votre plan couvre Tumor Markers
Obtenir une référence
Certains assureurs exigent une référence du médecin — nous pouvons vous guider
Pré-autorisation
Nous gérons la pré-autorisation directement avec votre assureur
Facturation directe
Pas de paiement initial — nous facturons directement votre assureur
Co-paiement uniquement
Vous ne payez que le co-paiement applicable à la clinique
Vérifier la couverture
Vérifiez que votre plan couvre Tumor Markers
Obtenir une référence
Certains assureurs exigent une référence du médecin — nous pouvons vous guider
Pré-autorisation
Nous gérons la pré-autorisation directement avec votre assureur
Facturation directe
Pas de paiement initial — nous facturons directement votre assureur
Co-paiement uniquement
Vous ne payez que le co-paiement applicable à la clinique
Votre spécialiste
Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
Persan · Arabe · Anglais
Conditions and Cancers Assessed Through Tumor Markers
Prostate Cancer
PSA is the primary screening and monitoring marker for prostate cancer, the most common non-skin cancer in men.
Ovarian Cancer
CA125 is used to evaluate suspected ovarian masses, monitor treatment response in diagnosed ovarian cancer, and surveil high-risk women with BRCA mutations or strong family history.
Pancreatic Cancer
CA19.9 supports the diagnosis and monitoring of pancreatic adenocarcinoma, with elevated levels correlating with tumor burden and helping predict surgical resectability.
Colorectal Cancer
CA19.9 may be elevated in colorectal malignancies and is sometimes used alongside CEA for monitoring treatment response and detecting recurrence.
Services connexes
Decouvrez d'autres services de diagnostic et de consultation disponibles dans notre clinique de Dubai Healthcare City.
Questions frequentes
Questions courantes sur Tumor Markers a Dubai.
Tumor markers are proteins produced by cancer cells or the body in response to cancer, measured through a blood test. They serve four functions: screening at-risk individuals, supporting diagnosis, monitoring treatment effectiveness, and detecting recurrence.
PSA (Prostate Specific Antigen) is produced by normal and cancerous prostate cells. Below 4.0 ng/mL is generally normal; 4.0-10.0 is a grey zone where approximately 25 percent may have cancer; above 10.0 carries higher probability.
CA125 is a protein elevated in ovarian cancer (80 percent of advanced cases) but also in endometriosis, fibroids, PID, and menstruation. It is most useful for evaluating women with persistent bloating, pelvic pain, or difficulty eating, and for monitoring diagnosed ovarian cancer.
CA19.9 is a protein shed by pancreatic and GI cancer cells. Below 37 U/mL is generally normal; above 100 U/mL is associated with pancreatic cancer.
Yes. PSA is elevated by BPH, prostatitis, and cycling.
Faits cles
Supervision medicale
Tous les services sont fournis sous la supervision de professionnels medicaux agrees dans notre etablissement accredite MOHAP.